Article citationsMore>>

Sletten, E.T., Arnes, M., Lysa, L.M., Moe, B.T., Straume, B. and Orbo, A. (2017) Prediction of Relapse after Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-Term Follow-Up Study. Anticancer Research, 37, 2529-2536.
https://doi.org/10.21873/anticanres.11595

has been cited by the following article:

• TITLE: Endometrial Hyperplasia with Conservative Treatment Using the Progestin or EP Agents, Compared to Cases that Worsen during Observation

  AUTHORS: Kenji Niwa, Saki Tsurue, Kentaro Niwa, Yoh Hayasaki, Masanori Isobe, Takuji Tanaka

  KEYWORDS: Endometrial Hyperplasia, Progestin, EP, PTEN-Null

  JOURNAL NAME: Open Journal of Pathology, Vol.16 No.1, January 4, 2026

  ABSTRACT: A total of 157 patients were included in this study, comprising 147 with simple Endometrial Hyperplasia (EH) and 10 with complex EH. All patients treated cyclically with progestin or Estrogen-Progestin (EP) exhibited regression of EH after 3 or 4 treatment courses. The relapse rate in patients treated cyclically with progestin was significantly lower than that in those treated with EP for simple EH (P